Effect of 1,25(OH)2D3 on BALB/c mice infected with Leishmania mexicana

Experimental Parasitology

Volumn 134, Issue 4, 2013, Pages 413-421

  Ramos Martinez E ^a   Villasenor Cardoso M I ^b   Lopez Vancell M R ^a   Garcia Vazquez F J ^c   Perez Torres A ^a   Salaiza Suazo, N ^a   Perez Tamayo R ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

1,25(OH)2D3; BALB c mice; Cutaneous leishmaniasis; Leishmania mexicana

Indexed keywords

CALCITRIOL; COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EOSINOPHIL COUNT; EPIDERMIS; FEMALE; FIBROBLAST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; INFLAMMATORY INFILTRATE; LEISHMANIA MEXICANA; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PARASITE CLEARANCE; PARASITE LOAD; PRIORITY JOURNAL; SKIN DEFECT; SKIN LEISHMANIASIS; TISSUE REPAIR; TREATMENT DURATION;

1,25(OH)2D3; BALB/C MICE; CUTANEOUS LEISHMANIASIS; LEISHMANIA MEXICANA;

ANIMALS; CALCITRIOL; COLLAGEN; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; SKIN;

ANIMALIA; LEISHMANIA MEXICANA; MUS;

EID: 84878920653     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2013.05.009     Document Type: Article

References (61)

1. Akuthota P., et al. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin. Exp. Allergy 2008, 38:1254-1263.
2. Anderson C.F., et al. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J. Immunol. 2005, 174:2934-2941.
3. Bailey M.S., Lockwood N.J. Cutaneous leishmaniasis. Clin. Dermatol. 2007, 25:203-211.
4. Baldwin T., et al. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in theear model of infection. Parasite Immunol. 2007, 29:501-513.
5. Belkaid Y., et al. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 2000, 165:969-977.
6. Bikle D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr. Opin. Nephrol. Hypertens. 2008, 17:348-352.
7. Bischoff-Ferrari H.A., et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
8. Blanchard C., Rothenberg M.E. Biology of the eosinophil. Adv. Immunol. 2009, 101:81-121.
9. Bogdan C., Rollinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol. 1998, 28:121-134.
10. Bryson K.J., et al. BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype. PLoS Negl. Trop. Dis. 2011, 5:e930.
11. Carlberg C., et al. The first genome-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res. 2011, 32:271-282.
12. Cordes T., et al. Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer. Anticancer Res. 2012, 32:351-357.
13. Curran C.S., Bertics P.J. Eosinophils in glioblastoma biology. J. Neuroinflamm. 2012, 9:11.
14. da Costa A., et al. IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol. Int. 2002, 51:367-379.
15. Deluca H.F., Cantona M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001, 15:2579-2585.
16. Di Rosa M., et al. Vitamin D3: a helpful immuno-modulator. Immunology 2011, 134:123-139.
17. Dickie L.J., et al. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford) 2010, 49:1466-1471.
18. Ehrchen J., et al. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major. FASEB J. 2007, 21:3208-3218.
19. Giudice A., et al. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect. Dis. 2012, 12:75.
20. Gorman S., et al. Vitamin D(3) deficiency enhances allergen-induced lymphocyte responses in a mouse model of allergic airway disease. Pediatr. Allergy Immunol. 2012, 23:83-87.
21. Griffin M.D., et al. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2011, 98:6800-6805.
22. Guerra C.S., et al. Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L.) amazonensis. Int. J. Exp. Pathol. 2010, 91:451-459.
23. Jones D.E., et al. IL-4 independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 2000, 165:364-372.
24. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med. 2010, 88:441-450.
25. Kaye P., Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 2011, 9:604-615.
26. Khoo A.L., et al. Translating the role of vitamin D(3) in infectious diseases. Crit. Rev. Microbiol. 2012, 38:12-135.
27. Kim H.R., et al. FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATD5 cells. BMB Rep. 2012, 45:287-292.
28. Kita H. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol. Rev. 2011, 242:161-177.
29. Kreutz M., et al. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993, 82:1300-1307.
30. Lezama-Davila C.M., Isaac-Marquez A.P. Systemic cytokine response in humans with chicleo's ulcers. Parasitol. Res. 2006, 99:546-553.
31. Maddahi A., et al. The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat. J. Neuroinflamm. 2011, 8:107.
32. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005, 15:599-607.
33. Mathieu C., et al. Seasonality of birth in patients with type 1 diabetes. Lancet 2002, 359:2148.
34. 3 on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 2010, 1803:1276-1286.
35. Meindl S., et al. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells. Br. J. Dermatol. 2005, 152:231-241.
36. Mukbel R.M. Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am. J. Trop. Med. Hyg. 2007, 76:669-675.
37. Prabhu A.S., et al. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine 2009, 45:105-110.
38. Proudfoot L., et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA 1996, 93:10984-10989.
39. Rajapakse M., et al. 1, 25-dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/c mice sensitivity to toxoplasmosis. J. Steroid Biochem. Mol. Biol. 2005, 96:179-185.
40. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995, 13:151-177.
41. Rosas L.E., et al. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice. Int. Immunol. 2005, 17:1347-1357.
42. Routsias J.G., et al. In vitro bactericidal activity of human beta defensin 2 against nosocomial strains. Peptides 2010, 31:1654-1660.
43. Sacks D. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev Imunol. 2002, 2:845-858.
44. Sakthianandeswaren A., et al. The wound repair response controls outcome to cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA 2005, 102:15551-15556.
45. Salaiza-Suazo N., et al. Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome. Trop. Med. Int. Health 1999, 4:801-811.
46. Saravia N.G., et al. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non murine models. Vaccine 2006, 24:4247-4259.
47. Shao T., et al. Vitamin d and breast cancer. Oncoligist 2012, 17:36-45.
48. Sigmundsdottir H. From the bench to the clinic: new aspects on immunoregulation by vitamin D analogs. Dermatoendocrinology 2011, 3:187-192.
49. Snyman J.R., et al. Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis. Eur. J. Clin. Pharmacol. 1997, 52:277-280.
50. Solbach W., Laskaym T. The host response to Leishmania infection. Adv. Immunol. 2000, 74:275-317.
51. Stafford J.L., et al. Macrophage-mediated innate host defense against protozoan parasites. Crit. Rev. Microbiol. 2002, 28:187-248.
52. Van Assche T., et al. Leishmania-macrophage interactions: insights into the redox biology. Free Radic. Biol. Med. 2001, 51:337-351.
53. Villaseñor-Cardoso M.I., et al. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host. Parasite Immunol. 2008, 30:425-434.
54. von Stebut E. Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur. J. Dermatol. 2007, 17:115-122.
55. von Stebut E., Udey M.C. Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect. 2004, 6:1102-1109.
56. Whitcomb J.P., et al. The role of vitamin D and vitamin D receptor in immunity to Leishmania major infection. J. Parasitol. Res. 2012, 2012:134645.
57. White J.H. Vitamin D signaling, infectious diseases and regulation of innate immunity. Infect. Immun. 2008, 76:3837-3843.
58. Wu C.C., et al. Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism. Tohoku J. Exp. Med. 2011, 223:153-159.
59. Xie Z., et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J. Invest. Dermatol. 2002, 118:11-16.
60. Youssef D.A., et al. Antimicrobial implications of vitamin D. Dermatoendocrinology 2011, 3:220-229.
61. Zhou Y., et al. 1,25-Dihydroxyvitamin D3 prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase. Allergy Asthma Proc. 2008, 29:258-267.